Biohope and C. Alan Foundation Named Winners of the 2022 Lyfebulb-Veloxis Innovation Challenge: Transforming Organ Transplantation
yahoo.com
news
2022-10-17 13:28:00

NEW YORK and CARY, N.C., Oct. 17, 2022 /PRNewswire/ -- Lyfebulb, a digital healthcare platform that bridges patients with industry to support user-driven innovation, education and connectivity, and Veloxis Pharmaceuticals, a fully integrated specialty pharmaceutical company, are excited to announce that Biohope was selected as the winner of the Innovation Award and C. Alan Foundation as the winner of the Impact Award at the 2022 Lyfebulb-Veloxis Innovation Challenge: Transforming Organ Transplantation.
